NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
NCT01521702
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Pancreas Cancer
Interventions
DRUG:
Neoadjuvant chemotherapy
PROCEDURE:
surgery and Adjuvant chemotherapy
Sponsor
Institut Paoli-Calmettes